Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acatris was a prominent international supplier of science-based health ingredients, primarily serving the nutraceutical and functional food industries. The company's portfolio was anchored by its proprietary branded ingredients, SoyLife (a soy-derived isoflavone complex) and LinumLife (a flax-derived lignan extract), which were marketed for their benefits in hormonal balance and cardiovascular health. Acatris differentiated itself through a focus on clinical research and regulatory compliance, providing standardized phytochemicals for use in dietary supplements. In October 2006, the company was acquired by Frutarom Industries for approximately $14.2 million, a move that significantly expanded Frutarom's presence in the health ingredients sector. Before the acquisition, Acatris was a subsidiary of the Dutch Schouten de Jager group and operated major facilities in Belgium and the Netherlands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Acatris.